Bodal Chemicals vs Gufic Biosciences vs Hexagon Nutrition: Which Stock Should You Track
- October 1, 2026
- Posted by: Neeraj Pandey
- Category: Market
Bodal Chemicals PE 36.26, mkt cap Rs 2,489 crore. Gufic Biosciences PE 58.98, mkt cap Rs 4,330 crore. Hexagon Nutrition PE 21.14, mkt cap Rs 837 crore.
Quick Answer
Bodal Chemicals vs Gufic Biosciences vs Hexagon Nutrition is a side-by-side comparison of three companies from the Speciality Chemicals space. On this comparison, Bodal Chemicals carries a market capitalisation of about Rs 2,489 crore against Rs 4,330 crore for Gufic Biosciences and Rs 837 crore for Hexagon Nutrition, with return on equity of 4.13%, 9.66% and 16.26% respectively. Each company’s numbers are presented here without a declared better pick, since the right stock depends on an investor’s own criteria.
Bodal Chemicals vs Gufic Biosciences vs Hexagon Nutrition starts with the core numbers most investors compare within the Speciality Chemicals segment: market capitalisation, valuation multiples, profitability and dividend yield. Figures below are sourced as of September 2026 and will shift with daily price moves.
All three names sit in the Speciality Chemicals bucket, which makes them a natural set to place side by side rather than a random trio of unrelated businesses.
Click Here – Get Free Investment Predictions
Bodal Chemicals, Gufic Biosciences and Hexagon Nutrition: Company Overview
Bodal Chemicals is a listed Indian company in the Speciality Chemicals space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
Gufic Biosciences is a listed Indian company in the Speciality Chemicals space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
Hexagon Nutrition is a listed Indian company in the Speciality Chemicals space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
Bodal Chemicals vs Gufic Biosciences vs Hexagon Nutrition: Valuation and Profitability Snapshot
| Metric | Bodal Chemicals | Gufic Biosciences | Hexagon Nutrition |
|---|---|---|---|
| Market Cap (approx.) | Rs 2,489 crore | Rs 4,330 crore | Rs 837 crore |
| PE Ratio (TTM) | 36.26 | 58.98 | 21.14 |
| PB Ratio | 2.15 | 6.51 | 2.90 |
| Return on Equity (ROE) | 4.13% | 9.66% | 16.26% |
| EPS (TTM, Rs) | 5.45 | 7.32 | 3.22 |
| Dividend Yield | 0.00% | 0.02% | 0.00% |
| Debt to Equity | 0.70 | 0.61 | 0.14 |
| Book Value per Share (Rs) | 91.91 | 66.31 | 23.48 |
Check the Univest Screener for Live Data
On valuation, Bodal Chemicals trades at a PE of 36.26 and a PB of 2.15, Gufic Biosciences at a PE of 58.98 and a PB of 6.51, while Hexagon Nutrition trades at a PE of 21.14 and a PB of 2.90. On return on equity, the three post 4.13%, 9.66% and 16.26% respectively, and on dividend yield they stand at 0.00%, 0.02% and 0.00%.
Bodal Chemicals vs Gufic Biosciences vs Hexagon Nutrition: Latest Quarterly Results
| Company | Latest Quarter Revenue | Latest Quarter Net Profit | YoY Change (Revenue) | QoQ Change (Revenue) |
|---|---|---|---|---|
| Bodal Chemicals | Rs 715.19 crore | Rs 30.38 crore | +56.1% | +21.1% |
| Gufic Biosciences | Rs 261.28 crore | Rs 22.31 crore | +16.3% | +4.2% |
| Hexagon Nutrition | Rs 106.39 crore | Rs 8.07 crore | -1.3% | -10.6% |
Quarterly figures above are the most recent reported quarter for each company (Q1 FY27, quarter ended June 2026), compared with the year-ago and preceding quarter.
Download the Univest iOS App or Univest Android App to track Bodal Chemicals, Gufic Biosciences and Hexagon Nutrition live prices.
What Should Investors Look at Beyond These Numbers?
Beyond the metrics above, investors comparing these three speciality chemicals names should track quarter-on-quarter revenue and margin trends, management commentary on demand and cost drivers, and any sector-specific regulatory developments, since a single-quarter snapshot can shift quickly.
Conclusion
Bodal Chemicals vs Gufic Biosciences vs Hexagon Nutrition highlights how differently three companies in the same speciality chemicals segment can score across valuation, profitability and dividend metrics, even when operating in a similar space. This comparison does not declare a winner; investors should weigh these figures against their own research and risk appetite. Please read the disclaimer below before making any investment decision.
Disclaimer: Data and figures in this article are sourced from publicly available information as of September 2026 and may not reflect real-time prices. Please verify all data independently before making any investment decision. This comparison does not recommend or endorse any single stock over another; investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Bodal Chemicals vs Gufic Biosciences vs Hexagon Nutrition
What is the market cap difference between Bodal Chemicals, Gufic Biosciences and Hexagon Nutrition?
Ans. As of September 2026, Bodal Chemicals has a market cap of approximately Rs 2,489 crore, Gufic Biosciences is at approximately Rs 4,330 crore, and Hexagon Nutrition is at approximately Rs 837 crore.
Which of the three has the highest PE ratio?
Ans. Among Bodal Chemicals, Gufic Biosciences and Hexagon Nutrition, the PE ratios stand at 36.26, 58.98 and 21.14 respectively as of September 2026.
Which of the three has the highest ROE?
Ans. Bodal Chemicals, Gufic Biosciences and Hexagon Nutrition post ROE of 4.13%, 9.66% and 16.26% respectively as of September 2026.
Which of these three stocks pays the highest dividend yield?
Ans. Bodal Chemicals, Gufic Biosciences and Hexagon Nutrition carry dividend yields of 0.00%, 0.02% and 0.00% respectively.
What is the debt to equity ratio for Bodal Chemicals, Gufic Biosciences and Hexagon Nutrition?
Ans. Bodal Chemicals carries a debt to equity of 0.70, Gufic Biosciences of 0.61, and Hexagon Nutrition of 0.14.
Which of the three trades at the highest price to book value?
Ans. Bodal Chemicals, Gufic Biosciences and Hexagon Nutrition trade at price to book ratios of 2.15, 6.51 and 2.90 respectively.
Is one of Bodal Chemicals, Gufic Biosciences or Hexagon Nutrition better than the others?
Ans. This comparison does not declare one stock better than another; each company scores differently across valuation, profitability and dividend metrics, and the right fit depends on an individual investor’s own criteria and research.
